Listen man. You are in love with this stock and it is killing you. You have been wrong all the time. Not arguing just telling you to fall out of love here. Look up radiant pharmaceutical and their approved cancer test. They screwed all investors. No different here.
Earnings weren't that bad. I expected higher 1.2 mill but we all know that the key is FDA clearance to get Abbott to take sales to where they should and will be. Cost cutting was amazing we can carry thru for another year before raising capital and by that time we get clearance Q3 or Q4
Agreed........they need to clear the deck for preparation and launch of the Galactin 3 Platform for Abbott. This a very small company that is dependent on their partners success as well as the approval from the FDA. This requires much patience....
Hang in there all.
Yup I agree selling now is crazy... That is a short wanting to start some panic selliing.
This company is still intached I see no reason why it would take that kind of hit. The
numbers were not that bad...
Do you guys know the status of the Automated VIDAS bioMerieux SA?
I know there were some positive clinical research studies in Jan 2014 and BGM stated "We are very pleased with the results obtained with the automated VIDAS Galectin-3 assay in this clinical research study," said Dr. Paul R. Sohmer, President and CEO of BG Medicine, Inc. "These results support commercialization of the VIDAS Galectin-3 assay in Europe and substantiate our efforts to assist bioMerieux with its pursuit of 510(k) clearance of the assay in the U.S."
But I haven't heard of any submissions.
I totally agree I strongly think approval will happen this Q. And automated sales next or early 2015. It could take up to a year for clearance which is within normal range, but I don't think it will be that long. We are in a good position for long term (3-6 months)
Yes we will have to wait one or two more quarters to see FDA clearance. But in mean time BGMD and Abbott are preparing for the launch of the automated test.
I am selling my shares. I don't trust the Management team. Sorry....I hope I am wrong and you all become millionaires.
From what I understood is that the more test results they can get, then the faster they can introduce the automated test version and gain wide acceptance. I think Abbott wants to prepare for the launch and they want to have as much literature possible in order to sell the test to the medical community. So I don't think it the FDA asking for more tests, but while they are waiting for the FDA response the idea is to generate as many clinical studies as possible to make it an easy sell once Cleared IMHO.
Have you ever been part of a start-up or building a company before? Based on your ignorant posts, I am guessing the answer is no
Now you can invest in that prediction and make some money. I guarantee that will be the next press release.
Let me let you in on what is probably going on. ABBOTT is about to end their relationship with this piece of junk.
I just dont see any reason for anyone to invest at this point. I will hold for
now with the hope the FDA news comes soon. I would be happy to see
a $1.50 by years end...